Last edition
News about "FDA Authorizes First Next Generation Sequence Test"
FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology
FDA Authorizes First Next Generation Sequence Test | 11/06/2020 | By Darshana | 808
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members